XML 87 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income $ 718,332 $ 434,883
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 456,685 435,878
Impairment charges 124,892 20,444
Debt Prepayment Refinancing Redemption Charges 33,402 0
Stock-based compensation expense 47,811 59,605
Deferred income taxes 72,590 200,056
Equity investment loss, net 5,131 8,611
Gain (loss) on sales of business interests, net 23,022 (57,547)
Other non-cash charges, net 24,291 164,856
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:    
Accounts receivable (182,684) (74,622)
Inventories 9,519 88,355
Other receivables and other current assets 51,319 (757)
Other long-term assets 2,324 2,142
Accounts payable (106,662) (12,800)
Accrued compensation and benefits (57,930) 40,225
Other current liabilities 140,046 45,624
Income taxes 57,279 21,749
Other long-term liabilities (27,542) 5,546
Net cash provided by operating activities 1,391,825 1,382,248
Cash flows from investing activities:    
Additions of property and equipment (547,183) (705,659)
Acquisitions (77,348) (113,526)
Proceeds from asset and business sales 3,863,619 135,268
Purchase of other debt and equity investments (5,160) (5,791)
Purchase of investments held-to-maturity (98,322) (3,728)
Proceeds from sale of other debt and equity investments 5,893 8,783
Proceeds from investments held-to-maturity 0 32,628
Purchase of equity investments (8,770) (12,874)
Distributions received on equity investments 1,296 3,580
Net cash provided by (used in) investing activities 3,134,025 (661,319)
Cash flows from financing activities:    
Borrowings 38,519,991 41,674,279
Payments on long-term debt and other financing costs (40,570,003) (40,828,443)
Purchase of treasury stock (1,837,022) (1,161,511)
Distributions to noncontrolling interests (157,170) (139,673)
Stock award exercises and other share issuances, net 7,333 8,803
Contributions from noncontrolling interests 44,095 43,179
Proceeds from sales of additional noncontrolling interest 0 15
Purchases of noncontrolling interests (10,988) (19,988)
Net cash used in financing activities (4,003,764) (423,339)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (4,178) (5,790)
Net increase in cash, cash equivalents and restricted cash 517,908 291,800
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year 415,420 518,920
Cash, cash equivalents and restricted cash of continuing operations at end of the period 1,357,141 540,155
Discontinued Operations    
Cash flows from financing activities:    
Net increase in cash, cash equivalents and restricted cash (423,813) 270,565
Continuing Operations    
Cash flows from financing activities:    
Net increase in cash, cash equivalents and restricted cash $ 941,721 $ 21,235